SS
Insider
Stephen L Sabba
DirectorStephen L Sabba (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $545K of LGND (2,145 sh × $254.00, as filed), executed Jun 16.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Jun 16
Filed Jun 18
Median ADV $104.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
LGNDRecent filings
LGNDSALE
Ligand Pharmaceuticals Incorporated
View filing →
$545K2,145 sh × $254.00
Exec Jun 16
Filed Jun 18 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $208K
1,000 sh × $207.87
Exec Mar 23
Filed Mar 25 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $410K
2,034 sh × $201.50
Exec Mar 3
Filed Mar 5 · 5:30 PM ET